The long-awaited findings bring the vaccine one step closer to a reality for parents of children ages 6 months to 4 years — the only group that remains ineligible for vaccination.
Results from the company’s Phase 2/3 clinical trial also found that the vaccine — which uses a dosage one-tenth the level used for adults — generated a strong immune response and that it was safe.
The 80% efficacy figure may change as the company gathers more data. It is based on 10 symptomatic cases of COVID that occurred seven days after the third dose of the vaccine as of April 29. A formal analysis will be performed once there are at least 21 positive cases in the clinical trial. The safety and immune response data are finalized, the company said.at least two months later.
Dr. Isaac Bogoch, an infectious disease specialist at the University of Toronto, said that while the findings are “helpful,” more data about the vaccine in young kids are still needed.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Pfizer 3-dose COVID vaccine 80% effective against symptomatic omicron infection for youngest children
Baca lebih lajut »
Pfizer covid shot 80 percent effective in young kids, early data showsThe results, along with other recent developments, signal that the long and frustrating wait for a vaccine for the youngest children, the last group to lack access, could be over within weeks.
Baca lebih lajut »
COVID-19 vaccine for kids under 5: Pfizer says 3 small doses offer strong protectionPfizer says it plans to give the data to U.S. regulators later this week. The 18 million tots under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.
Baca lebih lajut »
Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots.
Baca lebih lajut »
Pfizer Says 3 COVID Shots Protect Kids Under 5, Will Soon Send Data to FDAThe 18 million kids under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.
Baca lebih lajut »
Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in…
Baca lebih lajut »